Skin cancer treatments could be used to treat other forms of the disease

July 21, 2020

The creation of a silica nanocapsule could allow treatments that use light to destroy cancerous or precancerous cells in the skin to also be used to treat other types of cancer. Such are the findings of a study by INRS (Institut national de la recherche scientifique) professors Fiorenzo Vetrone and Federico Rosei, in collaboration with an international research team. Their results have been published in an article featured on the cover of the 26th edition of the Royal Society of Chemistry journal Chemical Science.

Photodynamic therapies, referred to as PDT, are treatments that use visible light to destroy cancerous or precancerous cells. Abnormal tissue is brought into contact with a light-activated and light-sensitive medication before it is exposed to light, triggering a chemical reaction that releases reactive oxygen species (ROS) to attack the diseased cells. In current treatments, the medication is injected into unhealthy tissue. But injection only works if tumours are on or under the skin, such as skin cancers.

The research team found a way around the limitation, so phototherapies can be used to treat other types of cancers as well. Thanks to silica nanoparticles doctors can use near-infrared (NIR) light, which penetrates further down into the tissue. The nanoparticles convert NIR light into visible light, triggering a chemical reaction and releasing ROS. "It's like we've reinforced the capsule that transports the treatment for diseased cells and increased the versatility of PDT. This nano superhero is stronger and more effective, even inside the body," explained Professor Vetrone, referring to the cover illustration depicting the team's discovery.

Developed by a team of chemists, magnetic resonance imaging (MRI) experts, and an oncologist, the new way of selectively enveloping light-sensitive medication in a nanocapsule could be beneficial for diagnosis and treatment. "Eventually, nanocapsules will help us expand the scope of application," added the professor.

Next, the team plans to test the nanoparticles in an in-vivo setting.
About the study

The research began in 2014 in collaboration with Xu Li, adjunct professor at INRS, senior scientist at the Institute of Materials Research and Engineering, and assistant adjunct professor at the National University of Singapore. Miao Wang, INRS PhD student under the joint supervision of INRS professors Vetrone and Rosei, is the lead author of "One pot synthesis of theranostic nanocapsules with lanthanide doped nanoparticles".

The co-authors of the article published by the Royal Society of Chemistry in the journal Chemical Science are Fiorenzo Vetrone, Federico Rosei, Artiom Skripka, Ting Chen (INRS); Michael Ng and Kishmore Kumar Bhakoo (Singapore Bioimaging Consortium, Singapore Agency for Science, Technology and Research); and Alex Y. Chang (Johns Hopkins University Singapore).

The study was funded by the Natural Sciences and Engineering Research Council of Canada, the Canada Foundation for Innovation, Fonds de recherche du Québec - Nature et technologie, the Canada Excellence Research Chairs Program, the Johns Hopkins Singapore Research Fund, and the Singapore Agency for Science, Technology and Research.

About the Institut national de la recherche scientifique (INRS) -

INRS is an academic institution dedicated exclusively to graduate research and training. Since its creation in 1969, it has actively contributed to the economic, social and cultural development of Quebec. INRS is 1st in Quebec and 2nd in Canada in terms of research intensity. It is composed of four interdisciplinary research and training centers located in Quebec City, Montreal, Laval and Varennes, which concentrate their activities in strategic sectors: Water Earth Environment, Energy Materials Telecommunications, Urbanization Culture Society and Armand-Frappier Health Biotechnology. Its community includes more than 1,500 students, postdoctoral fellows, faculty and staff.

Institut national de la recherche scientifique - INRS

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to